NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Track your stocks, dividends, monitor DRIP shares, and project your passive income.

Start Free »

ROIV | NASDAQ

$39.62 $0.00 | 0.00%

Next Earnings: Sep 15, 2026

Company Overview:

Market Cap: $0

Trailing PE: 0x

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $13.81 - $42.50

5.8 Year ROIV Performance Metrics:

Total Return (with DRIP): 281.0% (25.94% CAGR)

Total Return (no DRIP): 281.0% (25.94% CAGR)

Share Price: 281.0% (25.94% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $38,096

Total Return $ (with DRIP): $28,096

ROIV Total Return

1Y 2Y 5Y 10Y All

ROIV Price Chart

1Y 2Y 5Y 10Y All

DRIPCalc.com
ROIV Price

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)

Pro

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Start Free Trial

You save $57/yr (25%)

ROIV Earnings, Revenue, Cash & Debt, Shares Outstanding:

ROIV - Revenue

ROIV Revenue CAGR:1Y: -33.55%2Y: -57.52%5Y: 0.00%10Y: 0.00%

ROIV - Earnings Per Share (EPS)

ROIV EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - Net Income

🔒 Unlock

ROIV Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - EBITDA

🔒 Unlock

ROIV EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - Free Cash Flow

🔒 Unlock

ROIV Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - Free Cash Flow / Share

🔒 Unlock

ROIV Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - Operating Income

🔒 Unlock

ROIV Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - Gross Profit

🔒 Unlock

ROIV Gross Profit CAGR:1Y: -42.56%2Y: -61.41%5Y: 0.00%10Y: 0.00%

ROIV - Shares Outstanding

🔒 Unlock

ROIV Shares Outstanding CAGR:1Y: 5.95%2Y: -3.97%5Y: 0.00%10Y: 0.00%

ROIV - Share Buybacks

🔒 Unlock

ROIV Share Buybacks CAGR:1Y: -0.75%2Y: -43.53%5Y: 0.00%10Y: 0.00%

ROIV - Stock-Based Comp

🔒 Unlock

ROIV Stock-Based Comp CAGR:1Y: 1.42%2Y: 28.86%5Y: 0.00%10Y: 0.00%

ROIV - Expenses

🔒 Unlock

ROIV Expenses CAGR:1Y: -89.62%2Y: -34.11%5Y: 0.00%10Y: 0.00%

ROIV - Revenue vs Net Income

🔒 Unlock

ROIV - EPS vs FCF / Share

🔒 Unlock

ROIV - EPS vs PE Ratio

🔒 Unlock

ROIV - FCF vs FCF / Share

🔒 Unlock

ROIV - FCF vs Stock Based Comp

🔒 Unlock

ROIV - Cash & Debt

🔒 Unlock

ROIV - Revenue by Segment

🔒 Unlock

ROIV Revenue CAGR:1Y: -33.55%2Y: -57.52%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ROIV - REVENUE: Actual + Estimates

🔒 Unlock

ROIV Actual Revenue CAGR:1Y: -33.55%2Y: -57.52%5Y: 0.00%10Y: 0.00%

ROIV - EPS: Actual + Estimates

🔒 Unlock

ROIV Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - NET INCOME: Actual + Estimates

🔒 Unlock

ROIV Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - EBITDA: Actual + Estimates

🔒 Unlock

ROIV Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

ROIV - Net Profit Margin

🔒 Unlock

ROIV Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ROIV - Gross Profit Margin

🔒 Unlock

ROIV Gross Profit Margin CAGR:1Y: -13.55%2Y: -9.16%5Y: 0.00%10Y: 0.00%

ROIV - Price to Earnings

🔒 Unlock

ROIV - Price To Sales Ratio

🔒 Unlock

ROIV - Return on Capital Employed

🔒 Unlock

ROIV - Return on Invested Capital

🔒 Unlock

Projected Future Returns & Dividends for ROIV

Based on past 5.8-year performance, here are ROIV growth metrics:

Share price CAGR of +25.94%
Dividend CAGR of +0%

Using ROIV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

	ROIV (DRIP)	ROIV - No DRIP
Current Price	$39.62	$39.62
Start Shares	252.40	252.40
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	252.40	252.40
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$39.62	$39.62
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - ROIV

NOTE: Above numbers are our estimate based on ROIV's Dividend and Price CAGR over past 5.8 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

Pro

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Start Free Trial

You save $57/yr (25%)

Company Info

Roivant Sciences Ltd. (ROIV) had its IPO on 2020-12-08, and is trader on NASDAQ stock exchange.

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.

ROIV website: https://roivant.com

Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)

Pro

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Start Free Trial

You save $57/yr (25%)